APT Medical Inc. Share Price

Equities

688617

CNE100004C45

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 23:00:00 16/06/2024 BST 5-day change 1st Jan Change
444.9 CNY -0.35% Intraday chart for APT Medical Inc. -0.39% +14.51%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 2.2B 303M 23.84B Sales 2025 * 2.95B 406M 32B Capitalization 29.61B 4.08B 321B
Net income 2024 * 703M 96.91M 7.63B Net income 2025 * 947M 131M 10.28B EV / Sales 2024 * 13.5 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 10 x
P/E ratio 2024 *
45.2 x
P/E ratio 2025 *
33.1 x
Employees 2,155
Yield 2024 *
0.61%
Yield 2025 *
0.87%
Free-Float 50.09%
More Fundamentals * Assessed data
Dynamic Chart
APT Medical Inc. Announces Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders. CI
APT Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shenzhen Mindray Technology Announces Nominees for the Company's Second Board of Directors and Supervisory Board to APT Medical Inc. CI
Shenzhen Mindray Technology Holdings Co., Ltd. completed the acquisition of 19.72% stake in APT Medical Inc. from group of sellers. CI
APT Medical's 2023 Profit Jumps 49% MT
APT Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mindray Bio-Medical to Buy Controlling Stake in Medical Devices Maker For 6.7 Billion Yuan MT
Chinese medical device firm Mindray plans $927 million deal to control APT Medical RE
Shenzhen Mindray Technology Holdings Co., Ltd. agreed to acquire 19.72% stake in APT Medical Inc. from variou sellers for CNY6.2 billion. CI
APT Medical Forecasts Up to 58% Jump in 2023 Profit MT
Certain A Shares of APT Medical Inc. are subject to a Lock-Up Agreement Ending on 7-JAN-2024. CI
APT Medical Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
APT Medical Inc.(XSSC:688617) added to S&P Global BMI Index CI
APT Medical Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
APT Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
More news
1 day-0.35%
1 week-0.39%
Current month-9.76%
1 month-17.31%
3 months-2.06%
6 months+16.11%
Current year+14.51%
More quotes
1 week
432.50
Extreme 432.5
465.18
1 month
432.50
Extreme 432.5
548.11
Current year
310.02
Extreme 310.02
569.00
1 year
293.60
Extreme 293.6
569.00
3 years
140.97
Extreme 140.97
569.00
5 years
140.97
Extreme 140.97
569.00
10 years
140.97
Extreme 140.97
569.00
More quotes
Managers TitleAgeSince
Founder 59 16/06/02
Director of Finance/CFO 56 30/06/13
Chief Tech/Sci/R&D Officer 59 31/12/10
Members of the board TitleAgeSince
Director/Board Member 61 08/11/19
Director/Board Member 48 08/11/19
Founder 59 16/06/02
More insiders
Date Price Change Volume
17/06/24 444.9 -0.35% 859,593
14/06/24 446.4 -1.07% 1,863,865
13/06/24 451.3 -1.78% 868,111
12/06/24 459.5 +0.08% 576,225

End-of-day quote Shanghai S.E., June 16, 2024

More quotes
APT Medical Inc is a China-based company mainly engaged in the research and development, manufacture and sales of electrophysiological and vascular interventional medical devices. The Company's electrophysiological products include electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters and multichannel electrophysiological systems. Its coronary artery access products mainly include guide wires, micro catheters, balloons, contrast guide wires and catheters. The Company's peripheral vascular intervention products are mainly applied in peripheral vascular diseases. The Company is also engaged in related original equipment manufacturer (OEM) business. The Company distributes its products within domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
444.9 CNY
Average target price
497.1 CNY
Spread / Average Target
+11.74%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688617 Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW